FDA Approves Test for C. Difficile Meridian Bioscience – Results in an Hour
Posted Jul 15 2010 6:48am
C Diff, along with MRSA are one of the hospital acquired infections and can lead to death. C Diff has been associated with unsanitary conditions at some facilities and the NHS had real issues with C Diff a few years ago. At any rate the test can have results back in an hour which is faster than any other tests currently available. C Diff is an intestinal infection and there are sometimes more than one treatment to get rid of it and you can read about the last ditch effort below.
The process involves a stool transplant and is running about a 95% cure rate, so when faced with the choices of living with it, or giving this a try, I would think the procedure is now seen in an entirely different light. BD
Diagnostics company Meridian Bioscience Inc. (NSDQ:VIVO) received the go-ahead from the Food & Drug Administration to sell its first molecular test — illumigene C. difficile.
The Cincinnati life science company has has success making diagnostic test kits that detect pathogens like C. difficile which is a bacterium that can cause diarrhea and, in severe cases, a life-threatening inflammation of the colon.
Its illumigene testing system detects the presence of the toxin-producing region of the C. difficile DNA within an hour. Already launched in Europe, illumigene C. difficile uses an amplification technology that makes it easier and less expensive to use than some other molecular tests in the fast-growing market for rapid test kits.